Most Popular White Papers
Content provided in partnership with
Health Care Industry
Industry: Email Alert RSS FeedNovo Nordisk
Drug Store News, Oct 10, 2005 by James Frederick
Novo Nordisk last month received FDA aproval of NovoLog, a rapid-acting, insulin, analogue, for the treatment of diabetes in children.
The incidence of both type 1 and type 2 diabetes is increasing in children," stated Peter Aurup, vice president of clinical development, medical and regulatory affairs for Novo Nordisk. Approximately one in every 400 to 500 children and adolescents has type 1 diabetes.
NovoLog was approved by the FDA in 2000 for use in adults in the United States.
COPYRIGHT 2005 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
Find Research Guides for:
Find Featured Titles for: Business
- Academy of Marketing Science Review
- Accounting Historians Journal, The
- Accounting History
- AgExporter
- Agricultural Research
- Agricultural and Resource Economics Review
- Air Force Comptroller
- Air Safety Week
- Airline Industry Information
- American Demographics
- American Journal of Potato Research
- Architectural Review, The
- Asian Economic News
- Entrepreneur
Most Popular Articles in Health
- Fuel your workout: exercisers who eat before they work out have more energy ...
- Soothe a dry, itchy scalp: 5 easy expert solutions
- Cocktails and calories: Beer, wine and liquor calories can really add up. ...
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- The, six best supplements you've never heard of: these secret weapons can ...
- More »